z-logo
open-access-imgOpen Access
Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
Author(s) -
Cheong E. Von,
Ho Gwo Fuang
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4009
Subject(s) - lapatinib , trastuzumab , medicine , blockade , oncology , chemotherapy , cancer , breast cancer , receptor
The development of resistance to trastuzumab in HER2‐positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here